M1 Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$462K Sell
1,767
-2
-0.1% -$513 0.17% 72
2026
Q2
$445K Buy
1,769
+53
+3% +$11.4K 0.16% 74
2026
Q1
$373K Buy
1,716
+44
+3% +$9.8K 0.17% 78
2025
Q4
$382K Buy
1,672
+60
+4% +$13.7K 0.16% 79
2025
Q3
$373K Buy
1,612
+135
+9% +$27.5K 0.16% 79
2025
Q2
$274K Buy
1,477
+186
+14% +$34.6K 0.14% 86
2025
Q1
$271K Buy
1,291
+2
+0.2% +$389 0.17% 77
2024
Q4
$229K Buy
+1,289
New +$237K 0.12% 80

Other funds holding ABBV

M1 Capital Management's ABBV Position: Q3 2026 in Review

M1 Capital Management reduced its AbbVie (ABBV) stake by 0.11% in Q3 2026, selling an estimated $513 and leaving 1,767 shares worth $462K. The position accounts for 0.17% of the portfolio, ranked #72.

M1 Capital Management first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • M1 Capital Management held 1,767 shares of AbbVie worth $462K as of Q3 2026.
  • M1 Capital Management sold 2 AbbVie shares in Q3 2026, an estimated $513.
  • AbbVie made up 0.17% of M1 Capital Management's portfolio in Q3 2026, its #72 holding.
  • M1 Capital Management first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on M1 Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.